checkAd

     268  0 Kommentare Stratasys Releases Second Quarter 2021 Financial Results

    Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the second quarter of 2021.

    Second Quarter 2021 Financial Results Summary Compared to Second Quarter 2020:

    • Revenue of $147.0 million compared to $117.6 million.
    • GAAP gross margin was 43.0%, compared to 37.2%.
    • Non-GAAP gross margin was 47.5%, compared to 45.4%.
    • GAAP operating loss was $22.7 million, compared to an operating loss of $29.3 million.
    • Non-GAAP operating loss was $2.6 million, compared to an operating loss of $8.1 million.
    • GAAP net loss was $20.2 million, or $0.31 per diluted share, compared to a net loss of $28.0 million, or $0.51 per diluted share.
    • Non-GAAP net loss was $1.6 million, or $0.02 per diluted share, compared to a net loss of $7.4 million, or $0.13 per diluted share.
    • Adjusted EBITDA was $3.5 million, compared to $(1.6) million.
    • Cash provided by operations of $5.6 million, compared to cash use of $9.7 million.

    Dr. Yoav Zeif, Stratasys’s Chief Executive Officer stated, “Our strong second quarter results were highlighted by a 25% year over year revenue improvement with growth from all regions and all business lines. Our focus on manufacturing gained further traction, we increased the monetization and ecosystem partnerships of our software business, and we expanded our medical and dental offerings, advancing our plans for further penetration in the healthcare industry.”

    Dr. Zeif continued, “The transition of the 3D printing industry from prototyping to mass production is ongoing, and our commitment to being the first choice in polymer 3D printing positions us to be the main benefactor. We are investing across technology, software, materials, and talent to capture increased market share that we expect will yield significant returns and sustained profitability in the years to come.”

    Financial Outlook: (TBD)

    Based on current market conditions and assuming that the impact related to the pandemic does not impede the economic environment further, the Company is reiterating and updating its outlook as follows:

    • Third quarter 2021 revenue of approximately 17% - 18% growth year-over-year. Fourth quarter revenue is expected to be sequentially higher than third quarter.
    • Full year operating expenses expected to rise approximately $30 million compared to 2020, primarily due to the return of employees to a full-time schedule starting January 1, 2021, as well as operating costs as the markets gradually re-open.
    • Full year capital expenditures anticipated to range from $24 million to $30 million.
    • Longer term, the Company continues to expect significant leverage benefit from its investments as revenue growth should start to accelerate in 2022 and beyond.

    Stratasys Ltd. Second Quarter 2021 Webcast and Conference Call Details

    Lesen Sie auch

    The Company plans to webcast its conference call to discuss its second quarter 2021 financial results on Thursday, August 5, 2021 at 8:30 a.m. (ET).

    The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:

    https://78449.themediaframe.com/dataconf/productusers/ssys/mediaframe/ ...

    To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is +1-412-902-1012. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

    Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

    To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the company’s websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

    Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

    Cautionary Statement Regarding Forward-Looking Statements

    The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2021, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating acquisitions or investments in new businesses, technologies, products or services; the strength and duration of, and degree of recovery from, the COVID-19 pandemic in the markets in which we operate; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular (including risks related to the impact of coronavirus on our supply chain and business); costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D “Key Information - Risk Factors”, Item 4, “Information on the Company”, Item 5, “Operating and Financial Review and Prospects,” and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2020, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 1, 2021 (the “2020 Annual Report”). Readers are urged to carefully review and consider the various disclosures made throughout our 2020 Annual Report and the Reports of Foreign Private Issuer on Form 6-K that attach Stratasys’ unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly periods throughout 2021, which will be furnished to the SEC throughout 2021 (including on or about the date hereof), and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    Use of Non-GAAP Financial Measures

    The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our Company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions and divestments related expense or gains and reorganization-related charges or gains, and (ii) excluding non-cash items such as stock-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a comparable view of our performance to other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

     
    Stratasys Ltd.    
         
    Consolidated Balance Sheets    
    (Unaudited)    
    (in thousands, except share data)    
         
     

    June 30,

     

    December 31,

     

    2021

     

    2020

         
    ASSETS    
         
    Current assets    
    Cash and cash equivalents  

    $

    343,733

     

     

    $

    272,092

     

    Short-term deposits  

     

    179,000

     

     

     

    27,000

     

    Accounts receivable, net of allowance for credit losses of $0.8 and $0.9 million as of June 30, 2021 and December 31, 2020

     

    109,969

     

     

    106,068

     

    Inventories  

     

    124,227

     

     

     

    131,672

     

    Prepaid expenses  

     

    7,288

     

     

     

    6,717

     

    Other current assets  

     

    21,189

     

     

     

    16,943

     

         
    Total current assets  

     

    785,406

     

     

     

    560,492

     

         
    Non-current assets    
    Property, plant and equipment, net  

     

    201,080

     

     

     

    201,232

     

    Goodwill  

     

    39,686

     

     

     

    35,694

     

    Other intangible assets, net  

     

    124,257

     

     

     

    131,569

     

    Operating lease right-of-use assets  

     

    17,514

     

     

     

    21,298

     

    Other non-current assets  

     

    55,081

     

     

     

    39,717

     

         
    Total non-current assets  

     

    437,618

     

     

     

    429,510

     

         
    Total assets  

    $

    1,223,024

     

     

    $

    990,002

     

         
    LIABILITIES AND EQUITY    
         
    Current liabilities    
    Accounts payable  

    $

    42,001

     

     

    $

    16,987

     

    Accrued expenses and other current liabilities  

     

    30,134

     

     

     

    31,061

     

    Accrued compensation and related benefits  

     

    29,270

     

     

     

    25,659

     

    Deferred revenues - short term  

     

    48,943

     

     

     

    49,165

     

    Operating lease liabilities - short term  

     

    8,248

     

     

     

    9,282

     

         
    Total current liabilities  

     

    158,596

     

     

     

    132,154

     

         
    Non-current liabilities    
    Deferred revenues - long term  

     

    15,661

     

     

     

    14,227

     

    Operating lease liabilities - long term  

     

    9,553

     

     

     

    12,567

     

    Contingent consideration  

     

    40,436

     

     

     

    37,400

     

    Other non-current liabilities  

     

    37,206

     

     

     

    34,059

     

         
    Total non-current liabilities  

     

    102,856

     

     

     

    98,253

     

         
    Total liabilities  

     

    261,452

     

     

     

    230,407

     

         
    Redeemable non-controlling interests  

     

    227

     

     

     

    227

     

         
    Equity    
    Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 65,396 thousands shares and 56,617 thousands shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively

     

    181

     

     

    155

     

    Additional paid-in capital  

     

    2,992,833

     

     

     

    2,753,955

     

    Accumulated other comprehensive loss  

     

    (6,703

    )

     

     

    (8,846

    )

    Accumulated deficit  

     

    (2,024,966

    )

     

     

    (1,985,896

    )

    Total equity  

     

    961,345

     

     

     

    759,368

     

         
    Total liabilities and equity  

    $

    1,223,024

     

     

    $

    990,002

     

     
    Stratasys Ltd.
             
    Consolidated Statements of Operations
             
    (in thousands, except per share data)
             
     

    Three Months Ended June 30,

     

    Six Months Ended June 30,

     

    2021

     

    2020

     

    2021

     

    2020

     

    (unaudited)

     

    (unaudited)

     

    (unaudited)

     

    (unaudited)

    Net sales        
    Products  

    $

    100,305

     

     

    $

    73,877

     

     

    $

    190,629

     

     

    $

    157,049

     

    Services  

     

    46,700

     

     

     

    43,746

     

     

     

    90,565

     

     

     

    93,481

     

     

     

    147,005

     

     

     

    117,623

     

     

     

    281,194

     

     

     

    250,530

     

             
    Cost of sales        
    Products  

     

    49,731

     

     

     

    39,969

     

     

     

    96,651

     

     

     

    79,217

     

    Services  

     

    34,004

     

     

     

    33,918

     

     

     

    65,696

     

     

     

    67,707

     

     

     

    83,735

     

     

     

    73,887

     

     

     

    162,347

     

     

     

    146,924

     

             
    Gross profit  

     

    63,270

     

     

     

    43,736

     

     

     

    118,847

     

     

     

    103,606

     

             
    Operating expenses        
    Research and development, net  

     

    22,437

     

     

     

    21,303

     

     

     

    43,038

     

     

     

    45,497

     

    Selling, general and administrative  

     

    63,557

     

     

     

    51,711

     

     

     

    116,891

     

     

     

    107,287

     

     

     

    85,994

     

     

     

    73,014

     

     

     

    159,929

     

     

     

    152,784

     

             
    Operating loss  

     

    (22,724

    )

     

     

    (29,278

    )

     

     

    (41,082

    )

     

     

    (49,178

    )

             
    Financial income (expenses), net  

     

    (372

    )

     

     

    149

     

     

     

    (749

    )

     

     

    (680

    )

             
    Loss before income taxes  

     

    (23,096

    )

     

     

    (29,129

    )

     

     

    (41,831

    )

     

     

    (49,858

    )

             
    Income tax benefit  

     

    (4,368

    )

     

     

    (2,128

    )

     

     

    (5,310

    )

     

     

    (1,907

    )

             
    Share in losses of associated companies  

     

    (1,431

    )

     

     

    (950

    )

     

     

    (2,549

    )

     

     

    (1,788

    )

             
    Net loss  

     

    (20,159

    )

     

     

    (27,951

    )

     

     

    (39,070

    )

     

     

    (49,739

    )

             
    Net income (loss) attributable to non-controlling interests  

     

    -

     

     

     

    35

     

     

     

    -

     

     

     

    (50

    )

             
    Net loss attributable to Stratasys Ltd.  

    $

    (20,159

    )

     

    $

    (27,986

    )

     

    $

    (39,070

    )

     

    $

    (49,689

    )

             
    Net loss per ordinary share attributable to Stratasys Ltd.      
    Basic  

    $

    (0.31

    )

     

    $

    0.51

     

     

    $

    (0.63

    )

     

    $

    (0.91

    )

    Diluted  

    $

    (0.31

    )

     

    $

    0.51

     

     

    $

    (0.63

    )

     

    $

    (0.91

    )

             
    Weighted average ordinary shares outstanding        
    Basic  

     

    64,908

     

     

     

    54,917

     

     

     

    61,796

     

     

     

    54,733

     

    Diluted  

     

    64,908

     

     

     

    54,917

     

     

     

    61,796

     

     

     

    54,733

     

     
      Three Months Ended June 30,
     

    2021

      Non-GAAP  

    2021

     

    2020

      Non-GAAP  

    2020

      GAAP   Adjustments   Non-GAAP   GAAP   Adjustments   Non-GAAP
      U.S. dollars and shares in thousands (except per share amounts)
                 
    Gross profit (1)  

    $

    63,270

     

     

    $

    6,616

     

     

    $

    69,886

     

     

    $

    43,736

     

     

    $

    9,612

     

     

    $

    53,348

     

    Operating income (loss) (1,2)  

     

    (22,724

    )

     

     

    20,133

     

     

     

    (2,591

    )

     

     

    (29,278

    )

     

     

    21,228

     

     

     

    (8,050

    )

    Net income (loss) attributable to Stratasys Ltd. (1,2,3)  

     

    (20,159

    )

     

     

    18,581

     

     

     

    (1,578

    )

     

     

    (27,986

    )

     

     

    20,634

     

     

     

    (7,352

    )

    Net income (loss) per diluted share attributable to Stratasys Ltd. (4)  

    $

    (0.31

    )

     

    $

    0.29

     

     

    $

    (0.02

    )

     

    $

    (0.51

    )

     

    $

    0.38

     

     

    $

    (0.13

    )

                 
                 

    (1)

    Acquired intangible assets amortization expense    

     

    5,518

     

         

     

    4,065

     

     
    Non-cash stock-based compensation expense    

     

    788

     

         

     

    497

     

     
    Restructuring and other related costs    

     

    310

     

         

     

    5,050

     

     
       

     

    6,616

     

         

     

    9,612

     

     
                 

    (2)

    Acquired intangible assets amortization expense    

     

    2,200

     

         

     

    2,125

     

     
    Non-cash stock-based compensation expense    

     

    7,189

     

         

     

    5,614

     

     
    Restructuring and other related costs    

     

    350

     

         

     

    3,798

     

     
    Revaluation of investments    

     

    2,201

     

         

     

    -

     

     
    Contingent consideration    

     

    202

     

         

     

    -

     

     
    Other expenses    

     

    1,375

     

         

     

    79

     

     
       

     

    13,517

     

         

     

    11,616

     

     
       

     

    20,133

     

         

     

    21,228

     

     
                 

    (3)

    Corresponding tax effect    

     

    (1,637

    )

         

     

    (669

    )

     
    Equity method related amortization, divestments and impairments    

     

    85

     

         

     

    75

     

     
       

    $

    18,581

     

         

    $

    20,634

     

     

    (4)

    Weighted average number of ordinary shares outstanding- Diluted  

     

    64,908

     

       

     

    64,908

     

     

     

    54,917

     

       

     

    54,917

     

     
      Six Months Ended June 30,
     

    2021

     

    Non-GAAP

     

    2021

     

    2020

     

    Non-GAAP

     

    2020

     

    GAAP

     

    Adjustments

     

    Non-GAAP

     

    GAAP

     

    Adjustments

     

    Non-GAAP

      U.S. dollars and shares in thousands (except per share amounts)
       
    Gross profit (1)  

    $

    118,847

     

    $

    13,685

     

    $

    132,532

     

    $

    103,606

     

    $

    14,026

     

    $

    117,632

     

    Operating income (loss) (1,2)  

     

    (41,082

    )

     

    35,918

     

     

    (5,164

    )

     

    (49,178

    )

     

    32,719

     

     

    (16,459

    )

    Net income (loss) attributable to Stratasys Ltd. (1,2,3)  

     

    (39,070

    )

     

    33,692

     

     

    (5,378

    )

     

    (49,689

    )

     

    31,771

     

     

    (17,919

    )

    Net income (loss) per diluted share attributable to Stratasys Ltd. (4)  

    $

    (0.63

    )

    $

    0.55

     

    $

    (0.09

    )

    $

    (0.91

    )

    $

    0.58

     

    $

    (0.33

    )

       
       

    (1)

    Acquired intangible assets amortization expense  

     

    10,873

     

     

    8,130

     

    Non-cash stock-based compensation expense  

     

    1,422

     

     

    899

     

    Restructuring and other related costs  

     

    1,390

     

     

    4,997

     

     

     

    13,685

     

     

    14,026

     

       

    (2)

    Acquired intangible assets amortization expense  

     

    4,393

     

     

    4,267

     

    Non-cash stock-based compensation expense  

     

    13,760

     

     

    10,119

     

    Restructuring and other related costs  

     

    2,159

     

     

    3,829

     

    Revaluation of investments  

     

    (1,469

    )

     

    -

     

    Contingent consideration  

     

    393

     

     

    -

     

    Other expenses  

     

    2,997

     

     

    478

     

     

     

    22,233

     

     

    18,693

     

     

     

    35,918

     

     

    32,719

     

       

    (3)

    Corresponding tax effect  

     

    (2,394

    )

     

    (1,100

    )

    Equity method related amortization, divestments and impairments  

     

    168

     

     

    152

     

     

    $

    33,692

     

    $

    31,771

     

       

    (4)

    Weighted average number of ordinary shares outstanding- Diluted  

     

    61,796

     

     

    61,796

     

     

    54,733

     

     

    54,733

     

     



    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Stratasys Releases Second Quarter 2021 Financial Results Stratasys Ltd. (NASDAQ: SSYS) announced financial results for the second quarter of 2021. Second Quarter 2021 Financial Results Summary Compared to Second Quarter 2020: Revenue of $147.0 million compared to $117.6 million. GAAP gross margin was …

    Schreibe Deinen Kommentar

    Disclaimer